To help fuel investment and speed innovation, Phacilitate are commissioning an independent report that will be sent to 20,000 + investors and potential venture partners with the aim of promoting hard facts, data and in depth case studies demonstrating how and where investors can make money from the sector.

Working with an advisory board of industry leaders, analysts and KOLs, this comprehensive report will clarify the market outlook with an investment roadmap to 2020 and showcase the most promising companies and investment opportunities.

Through sponsoring, you can be integrally involved in the development of this industry leading report, raising your profile amongst an incredibly influential audience whilst positioning your company as a market leader and a business that is driving the growth of cell, gene and immunotherapy.

The report will focus on 4 areas:

  • Understanding Cell & Gene Therapy Pipelines
  • Building value for cell and gene therapies and establishing market access pathways
  • Manufacturing, Commercial Operations & Supply Chain
  • Understanding BioPharma interest and the strategic importance of a therapeutic/technology platform

If you would like to be involved in this report, or find out more about it, please contact Peter Harkness on +44 (0)20 7384 8027 or peter.harkness@phacilitate.co.uk.